An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
| Status: | Archived |
|---|---|
| Conditions: | Lupus |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2009 |
| End Date: | February 2011 |
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
This trial is conducted in North America. The aim of this clinical trial is to investigate
the safety, tolerability, pharmacokinetic and signs of bioactivity of increasing single
doses of AGS-009 in patients with systemic lupus erythematosus (SLE).
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials